These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1847120)

  • 41. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
    Imamura S
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ELISA in serodiagnosis of HCV infection.
    Pillot J; Rioche M; Lazizi Y
    FEMS Microbiol Rev; 1994 Jul; 14(3):221-7. PubMed ID: 7522020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The incidence and chronology of the appearance of anti-HCV in posttransfusional non-A, non-B hepatitis].
    Barcena R; Martín-de-Argila C; Ulibarrena C; Erdozain JC; Gil Grande LA; Mateos M
    Rev Esp Enferm Dig; 1993 Oct; 84(4):241-4. PubMed ID: 8292435
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatitis C viremia in German blood donors: serum alanine aminotransferase is not a valid marker for screening.
    Wolff C; Kleesiek K; Petersen N; Beyer J
    Transfusion; 1994 Apr; 34(4):361-2. PubMed ID: 7513910
    [No Abstract]   [Full Text] [Related]  

  • 46. [Different prevalence of hepatopathy among anti-HCV positive blood donors as a function of donation motive].
    Suárez A; Sotorrío NG; Rodríguez M; Rodrigo L
    Med Clin (Barc); 1993 May; 100(19):757. PubMed ID: 8391098
    [No Abstract]   [Full Text] [Related]  

  • 47. Testing for HCV markers.
    Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN
    Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testing for hepatitis C virus.
    Fagan EA
    BMJ; 1991 Sep; 303(6802):535-6. PubMed ID: 1655135
    [No Abstract]   [Full Text] [Related]  

  • 49. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
    Sugiyasu T
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved detection of antibodies to hepatitis C virus using a second generation ELISA.
    Lee S; McHutchinson J; Francis B; DiNello R; Polito A; Quan S; Nelles M
    Adv Exp Med Biol; 1992; 312():183-9. PubMed ID: 1381139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity.
    Mutimer DJ; Harrison RF; O'Donnell KB; Shaw J; Martin BA; Atrah H; Ala FA; Skidmore S; Hubscher SG; Neuberger JM
    BMJ; 1994 Oct; 309(6958):847-8. PubMed ID: 7524875
    [No Abstract]   [Full Text] [Related]  

  • 52. Testing of blood donations for hepatitis C virus.
    Dow BC; Follett EA; Jordan T; McOmish F; Davidson J; Gillon J; Yap PL; Simmonds P
    Lancet; 1994 Feb; 343(8895):477-8. PubMed ID: 7905968
    [No Abstract]   [Full Text] [Related]  

  • 53. [Liatek HCV: the six-antigen test for confirmation of the presence of anti-HCV antibodies].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(1-2):11-7. PubMed ID: 1282266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies to hepatitis C virus in low-risk blood donors: implications for counseling positive donors.
    Hsu HH; Gonzalez M; Foung SK; Feinstone SM; Greenberg HB
    Gastroenterology; 1991 Dec; 101(6):1724-7. PubMed ID: 1720106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
    Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
    Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody to hepatitis C virus and liver disease in volunteer blood donors.
    Alberti A; Chemello L; Cavalletto D; Tagger A; Dal Canton A; Bizzaro N; Tagariello G; Ruol A
    Ann Intern Med; 1991 Jun; 114(12):1010-2. PubMed ID: 1851402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C virus antibody in coagulopathic patients: ELISA and RIBA methods.
    Chistolini A; Filoni V; Dragoni F; Piro L; Mazzucconi MG; Isacchi G
    Haematologica; 1993; 78(4):252-4. PubMed ID: 7507458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of anti-HCV antibodies in France. Viral Hepatitis Study Group of the French Blood Transfusion Society.
    Aguelles O; Janot C
    Arch Virol Suppl; 1992; 4():249-52. PubMed ID: 1450696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-transfusion hepatitis.
    Ebeling F; Leikola J
    Ann Med; 1991 Oct; 23(4):361-6. PubMed ID: 1657047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C virus antibodies in dialysis pediatric patients.
    Di Loreto M; Ferrante M; Panaro A; Sorino P; Collela V; Caringella DA
    Nephron; 1992; 61(3):365-6. PubMed ID: 1323793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.